SomnoMed Ltd

SOM

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    22

Stocks News & Analysis

stocks

ASX gold miner under pressure to sell by activist investor

Activist investor presses gold miner on selling to larger players.
stocks

Ask the Analyst: Will Amcor lose its dividend aristocrat status?

When consistency becomes constraint.
stocks

Chart of the Week: We see opportunity in this beaten down industrial player

The market sees risks and are discounting the shares excessively.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,916.9058.60-0.65%
CAC 408,244.2993.871.15%
DAX 4024,916.19120.250.48%
Dow JONES (US)51,526.98839.911.66%
FTSE 10010,360.3228.020.27%
HKSE25,253.40379.81-1.48%
NASDAQ26,767.6186.36-0.32%
Nikkei 22567,470.69931.45-1.36%
NZX 50 Index13,101.6113.47-0.10%
S&P 5007,567.4213.740.18%
S&P/ASX 2008,686.1059.50-0.68%
SSE Composite Index4,057.7826.19-0.64%

Market Movers